Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NutriBand (NTRB) Research & Development (2021 - 2025)

NutriBand's Research & Development history spans 5 years, with the latest figure at $457113.0 for Q4 2025.

  • For Q4 2025, Research & Development fell 48.1% year-over-year to $457113.0; the TTM value through Oct 2025 reached $2.2 million, down 31.31%, while the annual FY2025 figure was $3.1 million, 59.1% up from the prior year.
  • Research & Development for Q4 2025 was $457113.0 at NutriBand, down from $562554.0 in the prior quarter.
  • Across five years, Research & Development topped out at $974535.0 in Q2 2024 and bottomed at $117814.0 in Q2 2022.
  • The 5-year median for Research & Development is $473484.5 (2025), against an average of $495367.4.
  • The largest annual shift saw Research & Development soared 239.88% in 2023 before it crashed 48.1% in 2025.
  • A 5-year view of Research & Development shows it stood at $161000.0 in 2021, then skyrocketed by 80.57% to $290718.0 in 2022, then surged by 89.7% to $551503.0 in 2023, then surged by 59.7% to $880768.0 in 2024, then plummeted by 48.1% to $457113.0 in 2025.
  • Per Business Quant, the three most recent readings for NTRB's Research & Development are $457113.0 (Q4 2025), $562554.0 (Q3 2025), and $683426.0 (Q2 2025).